NO20085182L - Behandling av tumorer hos pediatrikse pasienter med antagonister mot epidermal vekstfaktorresptor - Google Patents
Behandling av tumorer hos pediatrikse pasienter med antagonister mot epidermal vekstfaktorresptorInfo
- Publication number
- NO20085182L NO20085182L NO20085182A NO20085182A NO20085182L NO 20085182 L NO20085182 L NO 20085182L NO 20085182 A NO20085182 A NO 20085182A NO 20085182 A NO20085182 A NO 20085182A NO 20085182 L NO20085182 L NO 20085182L
- Authority
- NO
- Norway
- Prior art keywords
- tumors
- treatment
- antagonists
- growth factor
- factor receptor
- Prior art date
Links
- 102000001301 EGF receptor Human genes 0.000 title 1
- 108060006698 EGF receptor Proteins 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 208000012191 childhood neoplasm Diseases 0.000 abstract 2
- 229940122558 EGFR antagonist Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83348706P | 2006-07-27 | 2006-07-27 | |
| PCT/US2007/074448 WO2008014386A2 (en) | 2006-07-27 | 2007-07-26 | Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20085182L true NO20085182L (no) | 2009-04-24 |
Family
ID=38982334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20085182A NO20085182L (no) | 2006-07-27 | 2008-12-11 | Behandling av tumorer hos pediatrikse pasienter med antagonister mot epidermal vekstfaktorresptor |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2043688A4 (pt) |
| JP (1) | JP2009544736A (pt) |
| KR (1) | KR20090033841A (pt) |
| CN (1) | CN101484186A (pt) |
| AU (1) | AU2007279261A1 (pt) |
| BR (1) | BRPI0712368A2 (pt) |
| CA (1) | CA2654911A1 (pt) |
| CR (1) | CR10486A (pt) |
| EA (1) | EA200870603A1 (pt) |
| EC (1) | ECSP089011A (pt) |
| MX (1) | MX2008016187A (pt) |
| NO (1) | NO20085182L (pt) |
| TN (1) | TNSN08512A1 (pt) |
| WO (1) | WO2008014386A2 (pt) |
| ZA (1) | ZA200810600B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113853388B (zh) | 2019-03-27 | 2024-07-19 | 加拿大国家研究委员会 | 抗-egfrviii抗体及其抗原结合片段 |
-
2007
- 2007-07-26 EA EA200870603A patent/EA200870603A1/ru unknown
- 2007-07-26 CN CNA2007800249991A patent/CN101484186A/zh active Pending
- 2007-07-26 MX MX2008016187A patent/MX2008016187A/es not_active Application Discontinuation
- 2007-07-26 JP JP2009522001A patent/JP2009544736A/ja not_active Withdrawn
- 2007-07-26 WO PCT/US2007/074448 patent/WO2008014386A2/en not_active Ceased
- 2007-07-26 EP EP07813400A patent/EP2043688A4/en not_active Withdrawn
- 2007-07-26 AU AU2007279261A patent/AU2007279261A1/en not_active Abandoned
- 2007-07-26 CA CA002654911A patent/CA2654911A1/en not_active Abandoned
- 2007-07-26 KR KR1020087031606A patent/KR20090033841A/ko not_active Withdrawn
- 2007-07-26 BR BRPI0712368-0A patent/BRPI0712368A2/pt not_active Application Discontinuation
-
2008
- 2008-12-09 CR CR10486A patent/CR10486A/es not_active Application Discontinuation
- 2008-12-11 TN TNP2008000512A patent/TNSN08512A1/en unknown
- 2008-12-11 NO NO20085182A patent/NO20085182L/no not_active Application Discontinuation
- 2008-12-15 ZA ZA200810600A patent/ZA200810600B/xx unknown
- 2008-12-24 EC EC2008009011A patent/ECSP089011A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2043688A2 (en) | 2009-04-08 |
| CA2654911A1 (en) | 2008-01-30 |
| BRPI0712368A2 (pt) | 2012-06-05 |
| EP2043688A4 (en) | 2009-11-11 |
| CN101484186A (zh) | 2009-07-15 |
| KR20090033841A (ko) | 2009-04-06 |
| AU2007279261A1 (en) | 2008-01-31 |
| JP2009544736A (ja) | 2009-12-17 |
| TNSN08512A1 (en) | 2010-04-14 |
| WO2008014386A2 (en) | 2008-01-31 |
| ZA200810600B (en) | 2009-11-25 |
| EA200870603A1 (ru) | 2009-06-30 |
| CR10486A (es) | 2009-02-23 |
| ECSP089011A (es) | 2009-01-30 |
| MX2008016187A (es) | 2009-01-20 |
| WO2008014386A3 (en) | 2008-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011009020A3 (en) | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers | |
| EA200970953A1 (ru) | СПЕЦИФИЧНЫЕ ИНГИБИТОРЫ PDGFRβ | |
| NZ598145A (en) | Folate-targeted diagnostics and treatment | |
| EA201100971A1 (ru) | Производные пиримидининдола для лечения злокачественного новообразования | |
| MY150797A (en) | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer | |
| RU2015104537A (ru) | Способы лечения стромальных опухолей желудочно-кишечного тракта | |
| EA200970932A1 (ru) | Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа | |
| NO20073651L (no) | Antiangiogeneseterapi av autoimmunsykdom hos pasienter med mislykket tidligere terapi | |
| SG10201906270VA (en) | Combination therapy comprising a b-raf inhibitor and a second inhibitor | |
| WO2006017188A3 (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
| WO2012063134A3 (en) | Cardiac glycoside analogs in combination with emodin for cancer therapy | |
| TN2009000136A1 (en) | Sequential combination therapy | |
| MX2009003532A (es) | Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina. | |
| WO2008025033A3 (en) | Use of il-27 antagonists for the manufacture of a medicament for the treatment of aplastic anemia | |
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| NZ708802A (en) | Pharmaceutical combinations comprising a protein kinase c inhibitor compound and a mitogen activated protein kinase inhibitor compound | |
| MX2011009506A (es) | Antagonista del receptor mineralcorticoide y metodos de uso. | |
| NZ602807A (en) | 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one and an mtor inhibitor | |
| NO20085182L (no) | Behandling av tumorer hos pediatrikse pasienter med antagonister mot epidermal vekstfaktorresptor | |
| WO2007039123A3 (en) | Combination therapy comprising an nk-3 antagonist and an antipsychotic agent | |
| WO2008002544A3 (en) | Unit dosage forms of temozolomide | |
| CY1112203T1 (el) | Καινοτομικες θεραπευτικες χρησεις της αδρενεργικης αλφουζοσινης | |
| PL2465519T3 (pl) | Leczenie dysfunkcji śródbłonka u pacjentów z cukrzycą | |
| Defina | Efficacy of nilotinib in a patient relapse after 9 years of imatinib treatment and in stable complete cytogenetic response | |
| De Castro et al. | Treatment beyond progression: What to do when an epidermal growth factor receptor mutant-positive patient progresses to a tyrosine kinase inhibitor? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |